DrugPatentWatch Database Preview
Zydus Pharms Company Profile
» See Plans and Pricing
What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?
ZYDUS PHARMS has two hundred and ten approved drugs.
There are seventeen tentative approvals on ZYDUS PHARMS drugs.
Drugs and US Patents for Zydus Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms | DOXYCYCLINE | doxycycline | CAPSULE;ORAL | 205115-001 | Feb 18, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
Zydus Pharms | ENTECAVIR | entecavir | TABLET;ORAL | 206745-001 | Jun 23, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
Zydus Pharms | ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 210575-003 | Jun 4, 2020 | DISCN | No | No | Start Trial | Start Trial | |||||
Zydus Pharms | SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 207759-001 | Aug 11, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
Zydus Pharms | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 210395-001 | Sep 17, 2020 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.